InvestSMART

CurveBeam AI Limited (ASX: CVB) - Announcements

- Current share price for CVB : $0.019

ASX company news and announcements for CurveBeam AI Limited (CVB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CurveBeam AI Limited (CVB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CurveBeam AI Limited (CVB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CurveBeam AI Limited (CVB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Notification of cessation of securities - CVB 31 May 2024 1:38PM $0.185 $0.019 fallen by 89.73%
$9 Notice of Release from Voluntary Escrow 16 May 2024 4:43PM $0.175 $0.019 fallen by 89.14%
$9 Change of Director's Interest - Kate Robb - Dir Fees ZEPOs 8 May 2024 3:21PM $0.190 $0.019 fallen by 90%
$9 Change of Director's Interest - Hashan De Silva - Dir Fees 8 May 2024 3:20PM $0.190 $0.019 fallen by 90%
$9 Change of Director's Interest - Arun Singh - STI Share Right 8 May 2024 3:18PM $0.190 $0.019 fallen by 90%
$9 Change of Director's Interest - Rob Lilley - Dir Fees 8 May 2024 3:16PM $0.190 $0.019 fallen by 90%
$9 Late Lodgement - App 3Y Change of Dirs Interest Notices 8 May 2024 3:12PM $0.190 $0.019 fallen by 90%
$9 Investor Presentation - Quarterly Update - Q3 FY24 30 Apr 2024 9:03AM $0.165 $0.019 fallen by 88.48%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 8:51AM $0.165 $0.019 fallen by 88.48%
$9 Notification of quarterly release date & webinar 22 Apr 2024 9:39AM $0.180 $0.019 fallen by 89.44%
$9 CVB Presenting at ASX Small & Mid Cap Conference 27 Mar 2024 9:09AM $0.200 $0.019 fallen by 90.50%
$9 CVB Presentation for NWR Virtual Healthcare Conference 21 Mar 2024 9:19AM $0.195 $0.019 fallen by 90.26%
$9 CVB to present at NWR Virtual Healthcare Conference 18 Mar 2024 10:11AM $0.195 $0.019 fallen by 90.26%
$9 CVB - Commentary to App 4D - Dec 23 Half Year 29 Feb 2024 8:18AM $0.210 $0.019 fallen by 90.95%
$9 Appendix 4D - Interim Financial Report - Dec 2023 Half Year 29 Feb 2024 8:17AM $0.210 $0.019 fallen by 90.95%
$9 Application for quotation of securities - CVB 26 Feb 2024 12:47PM $0.215 $0.019 fallen by 91.16%
$9 Application for quotation of securities - CVB 26 Feb 2024 12:39PM $0.215 $0.019 fallen by 91.16%
$9 Notification regarding unquoted securities - CVB 20 Feb 2024 10:51AM $0.215 $0.019 fallen by 91.16%
$9 Notification regarding unquoted securities - CVB 20 Feb 2024 10:39AM $0.215 $0.019 fallen by 91.16%
$9 Securities released from escrow 13 Feb 2024 9:46AM $0.230 $0.019 fallen by 91.74%
$9 Application for quotation of securities - CVB 7 Feb 2024 12:14PM $0.220 $0.019 fallen by 91.36%
$9 CVB Presenting at Euroz Hartleys 2024 Healthcare Forum 6 Feb 2024 12:52PM $0.230 $0.019 fallen by 91.74%
$9 Notice of Securities to be Released from Escrow 31 Jan 2024 9:52AM $0.275 $0.019 fallen by 93.09%
$9 Q2 FY24 Investor Update Presentation for Webinar 30 Jan 2024 9:19AM $0.325 $0.019 fallen by 94.15%
$9 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2024 9:15AM $0.325 $0.019 fallen by 94.15%

176 - 200 of 287 results

Page 8 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.